Skip to content

Mean Systemic Filling Pressure Trends in Liver Transplant Recipients

Mean Systemic Filling Pressure Trends in Liver Transplant Recipients - a Prospective Observational Pilot Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04462874
Enrollment
20
Registered
2020-07-08
Start date
2020-07-15
Completion date
2021-12-15
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability, Liver Diseases, Liver Transplant; Complications

Keywords

liver transplantation, mean systemic filling pressure, advanced hemodynamic monitoring, liver cirrhosis

Brief summary

Patients with end stage liver disease undergoing liver transplantation have varying degrees of intraoperative haemodynamic unstability during various phases of transplantation. It is difficult to determine the cause for hemodynamic instability in these patients and to predict the best treatments. Currently, cardiovascular resuscitation options are triggered by arterial pressure and cardiac output (CO) measures, focusing on the oxygen delivery side of the circulation. The primary determinants of cardiac output reside on the venous side. Veins are 30-50 times more compliant than arteries and contain approximately 75% of the total blood volume. Mean systemic filling pressure provides vital information on this venous side of the circulation. Mean systemic filling pressure , which is defined as the pressure equal to the pressure which would be measured if the heart should suddenly stop pumping and all (arterial and venous) the pressures in the entire circulatory system should be brought to equilibrium instantaneously, is a good, complete and reliable reflection of the total intravascular fluid compartment. We would study the Mean systemic filling pressure in liver transplant recipients and record hemodynamic, respiratory, cardiac and renal function prospectively. Follow up data for 7 days for respiratory, cardiac and renal complications will be collected, along with hospital stay, ICU stay and mortality. The association between Mean systemic filling pressure and these outcomes will be analyzed.

Interventions

None listed

Sponsors

Institute of Liver and Biliary Sciences, India
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* all patients undergoing liver transplantation 18-65 years

Exclusion criteria

* pregnant patients acute liver failure, acute on chronic liver failure

Design outcomes

Primary

MeasureTime frameDescription
mean systemic filling pressures(MSFP)1 dayMSFP trends during liver transplantation, hourly

Secondary

MeasureTime frameDescription
icu stay28 daysduration of stay in the intensive care unit
28 day mortality28 daysmortality by all causes till day 28

Other

MeasureTime frameDescription
respiratory complications7 daysnumber of participants needing reintubation, prolonged mechanical ventilation, intercostal drain placement
acute kidney injury(AKI)7 daysAKI incidence upto 7 days
cardiac complication7 daysnumber of participants with significant arrhythmias and ischemia associated with hypotension

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026